NCT06509022Enrolling by invitation
Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
China Cancer Foundation Beijing Hope Marathon Fund
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
The goal of this observational study intends to explore the evolution trend and related factors of postoperative reflux of esophageal cancer based on PEPTEST detection, in order to identify postoperative reflux The main question it aims to answer are: to provide evidence for high-risk groups, improvement of surgical methods for esophageal cancer, and development of health education programs to prevent postoperative reflux. Using convenient sampling method, patients undergoing esophagectomy in thoracic surgery Department of Cancer Hospital of Chinese Academy of Medical Sciences from January 1, 2023 were continuously enrolled. PEPTEST was performed once before surgery, before discharge, 1 month, 3 months, and 6 months after surgery. The incidence of pathological reflux at 5 time points before and after surgery was observed and compared (that is, both T-line and C-line were shown). The trend of pepsin content in saliva before and after operation; The relationship between pathological reflux and surgical factors; The relationship between pathological reflux and life habits after operation; Relationship between pathological regurgitation and demographic characteristics.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 138 (estimated)
- First submitted
- 26 Aug 2023
- Start date
- 1 Mar 2024
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- NCT number
- NCT06509022
What you commit to
- Study type: Observational
- Planned participants: 138
- From 1 Mar 2024 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- People with cognitive impairment or mental illness.
- Complicating other serious life-threatening diseases (such as leukemia or autoimmune diseases).
Other
- Unwilling to participate in the study.
Who the study is looking for
- Patients who were pathologically diagnosed with esophageal cancer and underwent esophagectomy for esophageal cancer.
- The patient can communicate in Mandarin.
- Those who can come to the hospital for review on time.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.